Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Excellent Gold Intersections Verified at Kiimala Project May 12, 2025 Related Posts Top 5 Canadian Mining Stocks This Week: Bayhorse Silver Runs With 73 Percent Gain December 6, 2025 Editor’s Picks: Silver Price Smashes All-time High, Nearly Hits US$60 December 6, 2025 NioCorp Acquires FEA Materials to Build US Scandium Supply Chain December 6, 2025